Leveraging Continuous Glucose Monitoring Data as an Additional Source for Glucagon Prescription Behavior
Authors' conclusion
Glucagon prescription remains suboptimal among patients with hypoglycemia on CGM reports. Provider engagement via QI can increase glucagon prescription.
Study context
- Population
- Adults with T1D, or T2D on insulin, SU or meglitinide, in a tertiary care health system; chart review March–October 2023
- Participants
- 1,543 adults
- Exposure
- Hypoglycemia vs No hypoglycemia
- Hypoglycemian = 170
- Outcome
- Percentage of glucagon prescription in patients with hypoglycemia on CGM reports
Methodological detailssingle tertiary care health system
- Single tertiary care health system
Main finding
As reported in the abstract
Glucagon prescription in patients with time below range ≥4%
| Group | Value | Incident glucagon prescription |
|---|---|---|
| Hypoglycemia | 37% | 14% |
Hypoglycemia
Value37%
Incident glucagon prescription14%
- Hypoglycemia vs No hypoglycemia: P < 0.001 — 37% pre-existing prescription
Observational data: associations, not effects.
Further findings
| Outcome | No hypoglycemia | P value |
|---|---|---|
| Pre-existing or incident glucagon prescription by hypoglycemia severityBetween Mild and Severe | 28% | P < 0.001 |
| Pre-existing or incident glucagon prescription by hypoglycemia severityBetween Moderate and No hypoglycemia | P < 0.001 | |
| Pre-existing or incident glucagon prescription by hypoglycemia severityBetween Severe and No hypoglycemia | P < 0.001 |
- Pre-existing or incident glucagon prescription by hypoglycemia severity: Mild 38%
- Pre-existing or incident glucagon prescription by hypoglycemia severity: Moderate 49%
- Pre-existing or incident glucagon prescription by hypoglycemia severity: Severe 63%
Glucagon prescribed after provider education (quality improvement (QI)) · 4 weeks
- Patients whose providers received education who were prescribed glucagon
- 27 (39%) of 70
- Top choices: glucagon emergency kit, glucagon autoinjector, inhaled glucagon
Original publication
Leveraging Continuous Glucose Monitoring Data as an Additional Source for Glucagon Prescription Behavior. Endocr Pract. Published 28 October 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →